Larotrectinib is a selective TRK inhibitor, indicated for unresectable or metastatic NTRK-fusion-positive cancers. It picks out TRKA, TRKB, and TRKC—like they’re all different types of treasure, waiting to be claimed. You can get this as capsules—both 25 and 100 milligrams are a thing—and also as a tasty liquid, like 20 mg in every mil.
The recommended dose for adults is 100 mg twice daily, with pediatric dosing based on body surface area. You’ll find it in those bottles packed with 60 little capsule bombs.
